Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Component

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Application

  2.3.4 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1. Data & Biological Database Providers
3.4.2. AI Platform & Software Developers
3.4.3. AI-Driven Drug Repurposing Service Providers
3.4.4. Pharmaceutical Companies, Research Institutes & CROs

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 AI Model Performance & Drug Discovery Metrics

  4.1.1 Average Reduction in Drug Discovery Timelines Using AI Repurposing (%)

  4.1.2 Average Cost Savings Achieved per Repurposed Drug Candidate (USD Million)

  4.1.3 Prediction Accuracy of AI Models for Drug-Target Interactions (%)

  4.1.4 Average Number of Drug Candidates Identified Per AI Screening Campaign

  4.1.5 Percentage Increase in Clinical Trial Success Rates for AI-Repurposed Drugs (%)

 4.2 Technology Adoption & Platform Utilization Statistics

  4.2.1 Share of AI Drug Repurposing Platforms Utilizing Deep Learning Models (%)

  4.2.2 Percentage of Platforms Integrating Generative AI & LLM Capabilities (%)

  4.2.3 Share of Platforms Using Knowledge Graphs & Network-Based AI Approaches (%)

  4.2.4 Average Scale of Datasets Used for AI Model Training (Number of Data Points)

  4.2.5 Percentage of Platforms Offering Cloud-Based Deployment Models (%)

 4.3 Research & Clinical Trial Activity Indicators

  4.3.1 Annual Growth in AI-Identified Drug Repurposing Candidates Entering Clinical Trials (%)

  4.3.2 Average Time from AI Prediction to Preclinical Validation (Months)

  4.3.3 Percentage of Collaborations Between AI Firms & Pharmaceutical Companies (%)

  4.3.4 Share of Repurposed Drug Candidates Progressing to Phase II/III Trials (%)

  4.3.5 Number of Regulatory Filings Utilizing AI-Generated Repurposing Data

 4.4 Operational & Adoption Efficiency Indicators

  4.4.1 Average Improvement in Target Prioritization Efficiency Using AI (%)

  4.4.2 Percentage Reduction in False Positive Drug Candidates Through AI Screening (%)

  4.4.3 Average Automation Level in AI-Driven Drug Repurposing Pipelines (%)

  4.4.4 Percentage of AI Repurposing Projects Utilizing Multi-Omics Data Integration (%)

  4.4.5 Average Time-to-Decision for Drug Repurposing Candidate Selection (Weeks)

5. AI Drug Repurposing Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (USD Billion)

 5.1 Introduction
 5.2 Software & Platforms
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Services

6. AI Drug Repurposing Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

 6.1 Introduction
 6.2 Machine Learning/Deep Learning
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Natural Language Processing (NLP)
 6.4 Knowledge Graphs & Network-Based AI
 6.5 Generative AI & Large Language Models (LLMs)

7. AI Drug Repurposing Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

 7.1 Introduction
 7.2 Oncology
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022–2035
 7.3 Neurology
 7.4 Cardiology
 7.5 Infectious Diseases
 7.6 Rare & Orphan Diseases
 7.7 Other

8. AI Drug Repurposing Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

 8.1 Introduction
 8.2 Pharmaceutical & Biotechnology Companies
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022–2035
 8.3 Academic & Research Institutes
 8.4 Contract Research Organizations (CROs)

9. AI Drug Repurposing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 AI Drug Repurposing Market Size & Forecast, By Component, 2022–2035

  9.2.3 AI Drug Repurposing Market Size & Forecast, By Technology, 2022–2035

  9.2.4 AI Drug Repurposing Market Size & Forecast, By Application, 2022–2035

  9.2.5 AI Drug Repurposing Market Size & Forecast, By End Use, 2022–2035

  9.2.6 AI Drug Repurposing Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 AI Drug Repurposing Market Size & Forecast, By Component, 2022–2035

 9.3.3 AI Drug Repurposing Market Size & Forecast, By Technology, 2022–2035

 9.3.4 AI Drug Repurposing Market Size & Forecast, By Application, 2022–2035

 9.3.5 AI Drug Repurposing Market Size & Forecast, By End Use, 2022–2035

 9.3.6 AI Drug Repurposing Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 AI Drug Repurposing Market Size & Forecast, By Component, 2022–2035

 9.4.3 AI Drug Repurposing Market Size & Forecast, By Technology, 2022–2035

 9.4.4 AI Drug Repurposing Market Size & Forecast, By Application, 2022–2035

 9.4.5 AI Drug Repurposing Market Size & Forecast, By End Use, 2022–2035

 9.4.6 AI Drug Repurposing Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 AI Drug Repurposing Market Size & Forecast, By Component, 2022–2035

 9.5.3 AI Drug Repurposing Market Size & Forecast, By Technology, 2022–2035

 9.5.4 AI Drug Repurposing Market Size & Forecast, By Application, 2022–2035

 9.5.5 AI Drug Repurposing Market Size & Forecast, By End Use, 2022–2035

 9.5.6 AI Drug Repurposing Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 AI Drug Repurposing Market Size & Forecast, By Component, 2022–2035

 9.6.3 AI Drug Repurposing Market Size & Forecast, By Technology, 2022–2035

 9.6.4 AI Drug Repurposing Market Size & Forecast, By Application, 2022–2035

 9.6.5 AI Drug Repurposing Market Size & Forecast, By End Use, 2022–2035

 9.6.6 AI Drug Repurposing Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 Insilico Medicine

10.6.1.1 Company Overview & Snapshot

10.6.1.2 Product/Service Portfolio

10.6.1.3 Key Company Financials

10.6.1.4 Geographical Presence

10.6.1.5 SWOT Analysis

10.6.2 BenevolentAI plc
10.6.3 Recursion Pharmaceuticals, Inc.
10.6.4 Atomwise, Inc.
10.6.5 Healx Ltd.
10.6.6 Innophore GmbH
10.6.7 Owkin, Inc.
10.6.8 Schrödinger, Inc.
10.6.9 XtalPi Inc.
10.6.10 Isomorphic Labs Limited
10.6.11 Iktos SAS
10.6.12 twoXAR, Inc.
10.6.13 Verge Genomics, Inc.
10.6.14 Deep Genomics, Inc.
10.6.15 Valo Health, Inc.
10.6.16 Cellarity, Inc.
10.6.17 Genesis Therapeutics, Inc.
10.6.18 BostonGene Corporation
10.6.19 Iambic Therapeutics, Inc.
10.6.20 BullFrog AI Holdings, Inc.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures